Research Article
Traditional Chinese Medicine Improves Activities of Daily Living in Parkinson's Disease
Table 1
Patient characteristics.
| | Placebo () | ZAZ2 () |
| Age (yr) | 63.1 ± 10.2 | 62.82 ± 10.31 | Men/Women | 32/22 | 34/22 | Disease duration (yr) | 5.81 ± 3.24 | 5.73 ± 4.81 | Hoehn & Yahr stages | 2.35 ± 1.33 | 2.37 ± 1.13 | Levodopa/DCI (mg/day) | 396.61 ± 159.24 | 390.59 ± 164.71 | Pramipexole (mg/day) | 1.03 ± 0.69 | 1.00 ± 0.79 | Selegiline Hydrochloride (mg/day) | 8.97 ± 5.66 | 9.28 ± 4.95 |
|
|
DCI: decarboxylase inhibitor.
|